In summary, our study illustrates, for the first time, that patients with the XRCC1 (399Arg/Gln) genotype were more likely to experience severe acute radiation-induced dermatitis and oral mucositis after radiation therapy. This evidence concerns the gene XRCC1 and dermatitis.